Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Sad news

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Jun 09, 2021 9:40am

113 Views

Post# 33354266

RE:RE:RE:RE:RE:Sad news

I believe he was first dosed in early March so he likely survived very close to 3 months.

scarlet1967 wrote:

Apparently this gentleman was battling with prostate cancer for five years, the average five year survival rate for stage 4 prostate cancer is only 29% so he must have been a very sick at the start of the treatment, although the inclusion criteria is “expected 3 months minimum survival “ for late stage cancers I believe it is hard to predict that.

https://zh-tw.facebook.com/gettysburgtimes/posts/3896983050380010?locale2=zh_TW

juniper88 wrote: This came as a shock to me, especially when you consider one of the inclusion criteria of the trial:

"Have an expected survival of at least 3 months."

scarlet1967 wrote: Sad, my condolences to his family and love ones, it shows how desperately these grade 3 or 4 cancer patients need a treatment.

juniper88 wrote: My condolences to his family also. Sad news indeed.

jeffm34 wrote:
I think this might be TH's first patient in the cancer trial. Condolences to his family.

https://www.gettysburgtimes.com/obituaries/article_cb4e3798-3083-5062-9b44-9fd624857194.html

Apparently this gentleman was battling with prostate cancer for five years, the average five year survival rate for stage 4 prostate cancer is only 29% so he must have been a very sick at the start of the treatment, although the inclusion criteria is “expected 3 months minimum survival “ for late stage cancers I believe it is hard to predict that.

https://zh-tw.facebook.com/gettysburgtimes/posts/3896983050380010?locale2=zh_TW